11 May 2026
11 May 2026
Autonomous labs guided by AI can operate with increasing independence and are beginning to outperform human researchers.
Biktarvy continues to be a strong growth asset for Gilead, while Yeztugo’s launch rides an upward trajectory.
This framework comes as significant knowledge gaps remain around drug safety and efficacy in pregnancy.
The approval was based on results from the POETYK PsA-I and POETYK PsA-II Phase III clinical trials.
The analysis reviews the FY26 price revision by comparing the recent NHI-related price adjustments with observed price changes for the overall Japanese market in April 2026.
Customers have authorisation to use HEK293 functional cell lines for research, discovery, and assay development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
